SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence.

Autor: C, Underwood D, R, Osborn R, J, Kotzer C, L, Adams J, C, Lee J, F, Webb E, C, Carpenter D, S, Bochnowicz, C, Thomas H, W, Hay D, E, Griswold D

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; April 2000, Vol. 293 Issue: 1 p281-8, 8p